Drug Controller office in Gujarat to get zonal status

Image
BS Reporter Mumbai/ Ahmedabad
Last Updated : Jan 20 2013 | 7:34 PM IST

Keeping in view the concentration of pharmaceutical, medical devices, and growing clinical research organisations in Gujarat, the central government has decided to upgrade the Drug Controller’s office in Gujarat to Zonal office status.

“This would mean a lot of convenience, speedy clearance and approval to the pharmaceutical, medical devices, and clinical research industries, based in Gujarat,” said Surinder Singh, Drug Controller General of India (DCGI).

He said this at the opening session of a three-day event, InformExIndia 2009, on Thursday in Ahmedabad. He urged the industry to adapt to the global trends and practices in order to survive in today’s competitive environment.

Talking about the various initiatives that DCGI office has taken to improve the working of drug control offices in the country, Singh said that 62 more posts of drug inspectors had been cleared, which would help in speedy clearing of procedures.

Singh further said that in order to bring more safety and transparency, registration of all the organisations involved in clinical trails and research will be made mandatory and such organisation would be audited for the adherence to protocols and procedures for patient safety. He also informed that a registry of clinical research organisation would be made, which would have important data like design of CR, target and sponsors’ details.

He also announced that soon in consultation with Medical Council of India, vigilance centres will be established in select medical colleges of India, which will oversee the various aspects of safety and adherence of guidelines.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 13 2009 | 12:16 AM IST

Next Story